Report Detail
Global Uterine Fibroid Embolization Agents Market Professional Survey Report 2019
- RnM3772899 |
- 23 September, 2019 |
- Global |
- 109 Pages |
- QYResearch |
- Pharma & Healthcare
Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population. It is performed with the help of uterine fibroid embolization agents, delivered to the tumor by micro-catheters. The embolization agents block the arteries supplying blood to the tumor and force them to shrink.
The increased awareness about the uterine fibroids amongst women and popularity of minimally invasive procedure will drive the global market for uterine fibroid embolization agents. In addition, the fact that UFE allows woman to preserve their uterus, otherwise not possible with full or even partial hysterectomy will further drive the market.
The global Uterine Fibroid Embolization Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Uterine Fibroid Embolization Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Uterine Fibroid Embolization Agents market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Uterine Fibroid Embolization Agents in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Uterine Fibroid Embolization Agents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Astellas Pharma
Nippon Kayaku
Pfizer
Boston Scientific Corporation
Merit Medical Systems
Cook Medical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Gelatin Sponge
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Microspheres (TAGM)
Polymethyl Methacrylate (PMMA) Microspheres
Others
Segment by Application
Clinical Research Institutes
Hospital
Surgical Centers
Others
Table of Contents
Executive Summary
1 Industry Overview of Uterine Fibroid Embolization Agents
- 1.1 Definition of Uterine Fibroid Embolization Agents
- 1.2 Uterine Fibroid Embolization Agents Segment by Type
- 1.2.1 Global Uterine Fibroid Embolization Agents Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Gelatin Sponge
- 1.2.3 Polyvinyl Alcohol (PVA) Particles
- 1.2.4 Trisacryl Gelatin Microspheres (TAGM)
- 1.2.5 Polymethyl Methacrylate (PMMA) Microspheres
- 1.2.6 Others
- 1.3 Uterine Fibroid Embolization Agents Segment by Applications
- 1.3.1 Global Uterine Fibroid Embolization Agents Consumption Comparison by Applications (2014-2025)
- 1.3.2 Clinical Research Institutes
- 1.3.3 Hospital
- 1.3.4 Surgical Centers
- 1.3.5 Others
- 1.4 Global Uterine Fibroid Embolization Agents Overall Market
- 1.4.1 Global Uterine Fibroid Embolization Agents Revenue (2014-2025)
- 1.4.2 Global Uterine Fibroid Embolization Agents Production (2014-2025)
- 1.4.3 North America Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
- 1.4.4 Europe Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
- 1.4.5 China Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
- 1.4.6 Japan Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
- 1.4.8 India Uterine Fibroid Embolization Agents Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Uterine Fibroid Embolization Agents
- 2.3 Manufacturing Process Analysis of Uterine Fibroid Embolization Agents
- 2.4 Industry Chain Structure of Uterine Fibroid Embolization Agents
3 Development and Manufacturing Plants Analysis of Uterine Fibroid Embolization Agents
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Uterine Fibroid Embolization Agents Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Uterine Fibroid Embolization Agents
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Uterine Fibroid Embolization Agents Production and Capacity Analysis
- 4.2 Uterine Fibroid Embolization Agents Revenue Analysis
- 4.3 Uterine Fibroid Embolization Agents Price Analysis
- 4.4 Market Concentration Degree
5 Uterine Fibroid Embolization Agents Regional Market Analysis
- 5.1 Uterine Fibroid Embolization Agents Production by Regions
- 5.1.1 Global Uterine Fibroid Embolization Agents Production by Regions
- 5.1.2 Global Uterine Fibroid Embolization Agents Revenue by Regions
- 5.2 Uterine Fibroid Embolization Agents Consumption by Regions
- 5.3 North America Uterine Fibroid Embolization Agents Market Analysis
- 5.3.1 North America Uterine Fibroid Embolization Agents Production
- 5.3.2 North America Uterine Fibroid Embolization Agents Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Uterine Fibroid Embolization Agents Import and Export
- 5.4 Europe Uterine Fibroid Embolization Agents Market Analysis
- 5.4.1 Europe Uterine Fibroid Embolization Agents Production
- 5.4.2 Europe Uterine Fibroid Embolization Agents Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Uterine Fibroid Embolization Agents Import and Export
- 5.5 China Uterine Fibroid Embolization Agents Market Analysis
- 5.5.1 China Uterine Fibroid Embolization Agents Production
- 5.5.2 China Uterine Fibroid Embolization Agents Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Uterine Fibroid Embolization Agents Import and Export
- 5.6 Japan Uterine Fibroid Embolization Agents Market Analysis
- 5.6.1 Japan Uterine Fibroid Embolization Agents Production
- 5.6.2 Japan Uterine Fibroid Embolization Agents Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Uterine Fibroid Embolization Agents Import and Export
- 5.7 Southeast Asia Uterine Fibroid Embolization Agents Market Analysis
- 5.7.1 Southeast Asia Uterine Fibroid Embolization Agents Production
- 5.7.2 Southeast Asia Uterine Fibroid Embolization Agents Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Uterine Fibroid Embolization Agents Import and Export
- 5.8 India Uterine Fibroid Embolization Agents Market Analysis
- 5.8.1 India Uterine Fibroid Embolization Agents Production
- 5.8.2 India Uterine Fibroid Embolization Agents Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Uterine Fibroid Embolization Agents Import and Export
6 Uterine Fibroid Embolization Agents Segment Market Analysis (by Type)
- 6.1 Global Uterine Fibroid Embolization Agents Production by Type
- 6.2 Global Uterine Fibroid Embolization Agents Revenue by Type
- 6.3 Uterine Fibroid Embolization Agents Price by Type
7 Uterine Fibroid Embolization Agents Segment Market Analysis (by Application)
- 7.1 Global Uterine Fibroid Embolization Agents Consumption by Application
- 7.2 Global Uterine Fibroid Embolization Agents Consumption Market Share by Application (2014-2019)
8 Uterine Fibroid Embolization Agents Major Manufacturers Analysis
- 8.1 Astellas Pharma
- 8.1.1 Astellas Pharma Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.1.2 Astellas Pharma Product Introduction, Application and Specification
- 8.1.3 Astellas Pharma Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Nippon Kayaku
- 8.2.1 Nippon Kayaku Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.2.2 Nippon Kayaku Product Introduction, Application and Specification
- 8.2.3 Nippon Kayaku Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Pfizer
- 8.3.1 Pfizer Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.3.2 Pfizer Product Introduction, Application and Specification
- 8.3.3 Pfizer Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Boston Scientific Corporation
- 8.4.1 Boston Scientific Corporation Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.4.2 Boston Scientific Corporation Product Introduction, Application and Specification
- 8.4.3 Boston Scientific Corporation Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Merit Medical Systems
- 8.5.1 Merit Medical Systems Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.5.2 Merit Medical Systems Product Introduction, Application and Specification
- 8.5.3 Merit Medical Systems Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Cook Medical
- 8.6.1 Cook Medical Uterine Fibroid Embolization Agents Production Sites and Area Served
- 8.6.2 Cook Medical Product Introduction, Application and Specification
- 8.6.3 Cook Medical Uterine Fibroid Embolization Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
9 Development Trend of Analysis of Uterine Fibroid Embolization Agents Market
- 9.1 Global Uterine Fibroid Embolization Agents Market Trend Analysis
- 9.1.1 Global Uterine Fibroid Embolization Agents Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Uterine Fibroid Embolization Agents Regional Market Trend
- 9.2.1 North America Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.2.2 Europe Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.2.3 China Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.2.4 Japan Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.2.5 Southeast Asia Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.2.6 India Uterine Fibroid Embolization Agents Forecast 2019-2025
- 9.3 Uterine Fibroid Embolization Agents Market Trend (Product Type)
- 9.4 Uterine Fibroid Embolization Agents Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Uterine Fibroid Embolization Agents Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Uterine Fibroid Embolization Agents. Industry analysis & Market Report on Uterine Fibroid Embolization Agents is a syndicated market report, published as Global Uterine Fibroid Embolization Agents Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Uterine Fibroid Embolization Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
